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ABSTRACT 
Mucoadhesive dosage forms may be intended for facilitation of prolonged retention time at the application site hence providing drug release in a 
controlled rate for enhanced improvement of therapeutic activity and its outcome. The buccal mucosa has been investigated for systemic drug 
delivery and local drug treatment or therapy that is subjected to first pass metabolism. The applicability of bio-adhesion approach in buccal drug 
delivery proved great therapeutic potential to overcome the limitation of conventional buccal drug delivery. The delivery via buccal route using 
mucoadhesive biopolymers such as various natural gums e.g. carrageenans, gum karaya, gum arabic, locust bean gum, khaya gum, gum ghatti, 
albizia gum, guar gum, starch, cellulose, larch gum and pectin etc. and various thiolated and carboxymethylated polymers has been the subject of 
interest since the early 20th century. The present article is focused mainly on the oral mucosa, mechanism of drug permeation, and characteristics of 
the desired polymers, the manuscript then proceeds to cover the theories behind the adhesion of bioadhesive polymers to the mucosal epithelium 
followed by the factors affecting mucoadhesion. Further the author has also discussed on the new generation of mucoadhesive polymers and their 
properties, recent mucoadhesive formulations for enhanced buccal drug delivery, various marketed products and patent literature. Various online 
search engines and scientific journals were employed for the collection of literature and scientific data and information related to the topic using 
keywords like mucoadhesive polymers, buccal drug delivery, buccal patches, tablets, films, gels, powder from the year 2002 and above. 
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Mucoadhesion or mucosal adhesion is defined as the state which is 
responsible for the adhesion between two materials for a definite 
material of time. With the help of interfacial forces between two 
materials, the adhesion occurs and the phenomenon known as 
bioadhesion (biologically adherence between two materials, when 
one of the material is biological in nature) [1]. The mucoadhesion 
was first introduced in 1980’s for delivering the drug in controlled 
manner and providing the ease of controlled drug delivery. This 
concept of mucoadhesion is a new approach for the improvement of 
drug efficacy for various drug delivery systems. In systemic delivery 
the formulation is kept for intimate contact with tissue or cells at the 
site of absorption. In nasal, vaginal and local drug delivery it is 
carried out by spatial placement within gastrointestinal tract 
(absorption site is in gastro region) [2]. Over the last two decades 
mucoadhesion has become an area of interest for the administration 
of various unstable bioactive via different route of administration 
(nasal, vaginal, ocular and buccal which are generally difficult to 
administer by oral route). Mucoadhesive material can also be used 
as therapeutic agent as it coat and protects the damaged tissues or 
act as lubrication agents. Mucoadhesion is due to formation of non-
covalent bonds such as hydrogen bonds and ionic interactions or 
physical entanglements between the mucus gel layer and polymer. 
Additionally, the residence time of dosage form in the Gastro 
intestinal mucosa should be prolonged, which allows a constant 
drug release at a given aim site to maximize the therapeutic effect 
[3]. There are many factors that depend on mucoadhesion as shown 
in (fig. 1). 
The oral cavity is a preferred site for the transmucosal delivery of 
drugs. Buccal route offers advantages like avoidance of first pass 
metabolism and gastrointestinal degradation of drugs, high blood 
flow which ensures systemic drug bioavailability [4]. Various buccal 
bioadhesive polymers are available for ascertaining adhesive contact 
with the buccal mucosa thereby increasing the buccal residence time 
of the delivery system for optimal drug bioavailability. Some 
properties of the polymers affecting bioadhesive potential includes, 
number of hydrogen bonding groups, charge, molecular weight, 
chain flexibility, and surface energy properties [5]. A range of 
natural and synthetic polymers are available for developing different 
bioadhesive drug delivery systems.  
 
Fig. 1: Different factors affecting the process of mucoadhesion 
 
Approaches/theories of mucoadhesion 
Wetting theory 
The wetting theory is generally applied in mucoadhesive system 
(liquid) having low viscosity. The theory postulates about the 
mucoadhesive polymer ability that easily spreads on biological 
surface which leads to the extensively spreading ability of active 
drug delivery systems. This theory describes that the adhesive 
constituent penetrates in irregularities in surface which hardens and 
get attached to the surfaces because of drastic changes occurs in 
surfaces and interfacial energies [2]. The adhesive mechanism of 
such elastoviscous liquid may be defined by using wettability and 
spreadability as shown in (fig. 2). The contact angle techniques are 
based on the principle that lowers the contact angle, these are used 
to determine the affinity of a liquid to measure contact angle of the 
liquid on the surface. The theory postulates that the lower the 
contact angle, the greater will be the affinity of liquid to the solid 
surface [6].  
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Fig. 2: Shows penetration of dosage form into the surface or 
tissue of the mucosal layer by wetting or swelling mechanism 
Adsorption theory 
Adhesion is defined as the result of interactions in various surfaces 
(primary and secondary) are two types of chemical bonds for 
adhesive interactions i. e hydrogen bond and Vandar waals’ forces 
are deep-rooted between the adhesive polymer and mucus substrate 
which is depicted in (fig. 3). Primary bonds occurs due to the 
chemisorptions which results in adhesion due to ionic, covalent and 
metallic bonding, while the secondary bonds arises mainly due to 
Vander waals forces, hydrophobic interactions and hydrogen 
bonding [7]. 
Electronic theory 
This theory tells that the adhesion occurs due to electron transfer 
between the mucus and the mucoadhesive system which is arises 
through differences in their electronic structure. The electron 
transfer between the mucus and the mucoadhesion results in the 
formation of bi-layer of electronic charges formed at the mucus and 
mucoadhesive system interface as shown in (fig. 4) [8, 9]. 
  
 
Fig. 3: Indicates the stages concerned with mucoadhesion: first stage shows the interaction of drug delivery system on the surface of 
mucus membrane; second stage shows several physicochemical interactions, results in prolonged adhesion at the site of action 
 
 




This theory describes the adhesive bonds between systems that are 
related to the force that are required to impart or separate both 
surfaces from one another. This includes that the force required for 
polymer detachment from the mucus to the basic strength of their 
adhesive bonds. It has been found that when the polymer network 
strands are longer, or the degree of cross-linking within system is 
reduced the greater will be the work of fracture. This theory also 
allows the determination or measurement of fracture strength (σ) 
which leads to the separation of two surfaces using young’s modulus 
of elasticity (E), the critical crack length (L) and the fracture energy 
(ε) through following equation [9]. 
σ=√(E*ε)/l 
Diffusion interlocking theory 
This theory is a two-way diffusion process which proposes the time 
dependent diffusion of mucoadhesive polymer chains into the 
glycoprotein chain network of the mucus layer and the penetration 
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rate is being dependent upon the diffusion coefficient of both 
interacting polymers as indicated in (fig. 5) Moreover, there are 
many factors and properties that significantly influence this 
diffusion are cross-linking density, chain mobility or flexibility, 
molecular weight and expansion capacity of both networks and 
temperature (as important environmental factor). Although it is 
recognized that longer polymer chains may diffuse, interpenetrate 
and ultimately entangle to a greater extent with surface mucus, it 
should be recognized that a critical chain length of at least 100 kDa 
is necessary to obtain interpenetration and molecular entanglement. 
Another significant contributory factor in determining 
interpenetration is the miscibility of both systems with one another. 
The time at which maximum adhesion occurs between two 
substrates during interpenetration has been supported by 
experimental evidence in recent studies using FTIR and rheological 
techniques, and may be determined using the depth of 
interpenetration and the diffusion coefficient [9]. 
Mechanical theory 
The mechanical theory considers adhesion due to filling of 
irregularities on a rough surface by a mucoadhesive liquid. 
Additionally, such irregularity increases the interfacial area 
available for interaction and can be considered the most important 
phenomenon of the process as depicted in (fig. 6) [10]. 
 
 
Fig. 5: Diffusion Interlocking of the mucoadhesive polymer with 
glycoprotein mucin chain 
 
 
Fig. 6: Formation of contact angle between the gastric mucosal surface and the interface 
 
Muco-adhesive polymers 
Muco-adhesive polymers are mainly water soluble in nature 
however some can be water insoluble too. These polymers have 
swellable networks. Networks are joined with the help of some cross 
linking agents. These cross linking agents have various important 
properties which are required for muco-adhesion like easy wetting, 
better mutual adsorption and better penetration and 
interpenetration ability within the polymer and the oral mucus. 
These muco-adhesive polymers which have ability to bind with the 
mucus present on the epithelial cells surfaces can further be divided 
into three classes [11-13]. 
1. Polymers which have ability to become sticky when these are 
placed in water. These polymers also have their own muco-adhesion 
power to achieve better stickiness. Examples are collagen, gelatin, 
starch, alginate, and agarose [14]. 
2. Polymers which have ability to adhere with the epithelia surface 
by virtue of their electrostatic nature (Hydrogen bonding can play 
significant role in these polymers in order to achieve better 
adhesion). Examples are carboxy methyl cellulose, carbopol, sodium 
alginate, hydroxyl propyl methyl cellulose [15]. 
3. Polymers that have ability to bind with the specific receptors and 
hence can be helpful in order to achieve better drug targeting 
through their site specific recognition power [16]. 
Some important characteristics of ideal muco-adhesive 
polymers  
The mucoadhesive polymer as well as its degradation products must 
be non-toxic in nature. Other than the non-toxicity these 
degradation products and the polymer should be non-absorbable 
from the site of administration. The mucoadhesive polymer as well 
as its degradation products must be non-irritant to mucous surface 
where it is applied. The mucoadhesive polymer as well as its 
degradation products should have ability to form strong non 
covalent bonds with mucin epithelial cells [17]. This will avoid the 
polymeric buccal formulation to shift from the site of administration 
because of the buccal movements which are produced by talking, 
drinking and eating etc. The mucoadhesive polymer should have 
ability to adhere quickly to most of the tissues where it is applied. It 
should also have site specificity[18]. The mucoadhesive polymers 
should have ability to allow the incorporation of the daily 
requirement of the drug. These polymers should not produce any 
hindrance in the way of drug release. These polymers should not 
decompose during their storage period. These should have required 
shelf life which can help to make the preparation same as before 
without any degradation for long period of time. These 
musoadhesive polymers should be low of cost and should be easily 
accessible and easy to produce and manufacture [19]. 
Classification of muco-adhesive polymers  
These muco-adhesive polymers can be divided into two broad 
categories:  
Natural Polymers: Derived from natural origin for example: collagen, 
albumin, alginates, gelatin, cyclodextrins, chitosan, dextran, starch, 
agarose, cellulose, hyaluronic acid extra. 
Synthetic polymers: These are further divided into two categories:  
A) Bio-degradable polymers: Polylactic acid, Polyhydroxyl butyrate, 
Polyglycolic acid, Polycaprolactone, Poly-Doxanones, Polyadipic acid, 
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Polysebacic acid, Polyterphthalic acid, Poly iminocarbonates, Poly 
amino acids, Polyphosphates, Polyphosphazenes, Polyphosphonates, 
Poly urethanes, Polyacetals, Poly-ortho esters etc [20]. 
B) Non biodegradable polymers: Carboxymethylcellulose, Ethyl 
cellulose, Polydimethyl siloxanes, Cellulose acetate HPMC, Collodial 
silica, Polymethacrylates, Poloxamines etc. 
Polymers used in buccal drug delivery based upon their category are 
depicted in (table 1) [21]. 
Natural polymers 
Collagen  
Collagen is one of the natural protein polymers which is widely used 
for muco-adhesion. Collagen polymer has a triple helical structure. 
With time the collagen polymer is further modified and various 
types of these polymers have been isolated. There are about 
nineteen different types of collagen monomers which have been 
isolated, characterized, and tested for both pharmaceutical and 
medical interests [22]. Collagen has various attractive properties 
like good biocompatibility, degradability, low antigenicity which 
makes the collagen polymer to be used widely in various 
pharmaceutical, tissue and medical applications in drug delivery 
systems [23].  
Abruzzo et al., 2012, successfully discovered buccal delivery of 
active drug propranolol hydrochloride by using chitosan and gelatin 
dual polymeric films. The FT-IR and TGA studies showed that there 
are appropriate and acceptable interactions between the gelatin and 
chitosan polymers. The investigator used the high concentration of 
chitosan in the chitosan/gelatin films because by using the high 
amount of chitosan there is lowest percentage of water uptake 
ability which is found to be about 235.1±5.3 % [24]. The high 
amount of chitosan in the dual polymeric films also helped in 
high residence time of the prepared formulation in the buccal cavity 
when tested in vivo. The residence time was found to be about 
240±13 min. The use of mannitol in prepared formulation showed 
better permeation of the drug when tested through porcine buccal 
mucosa. Near about 80% drug permeation was found when tested 
on porcine buccal mucosa when applied for around 5 h. Another 
interesting point of using the chitosan/gelatin conjugated dual 
polymeric films was their better compatibility with the microflora 
environment of buccal mucosa [25]. 
Gelatin 
Gelatin is an example of natural polymers commonly found in 
nature. Gelatin is a water soluble polymer which is basically 
produced through the process known as denaturation. Denaturation 
of collagen polymer resulted in the formulation of gelatin [25]. This 
polymer is also widely used in pharmaceutical, tissue and medical 
applications. Gelatin polymer has outstanding physical and chemical 
properties. It is biocompatible, biodegradable and of low 
antigenicity. Gelatin is also a supporting material which can be used 
for cell culture, gene delivery and tissue engineering. The 
formulations, in which gelatin is used, have the ability to incorporate 
as well as release the bioactive agents like active drugs, proteins and 
peptides, dual growth factors etc. [26]. 
Albumin 
In order to prepare muco-adhesive gels by using albumin, it is first 
modified by conjugating with the PEG. These modified albumin 
containing hydrogels were later used in tissue engineering scaffold 
materials. Albumin and its derivates are widely used for drug 
delivery by various pharmaceutical researchers. These are also used 
in tissue engineering applications. These polymers have adequate 
biocompatibility, low toxicity, biodegradability, non-
immunogenicity, relatively low cost, water solubility, gelling ability, 
high viscosity and stabilizing properties [27]. 
Dextran 
Dextran is also one of the most widely used natural polymer for 
mucoadhesive gel formulation. This dextran polymer is a type of 
natural linear polymer in which 1-6 glucopyranoside linked 
polymer. Dextran is basically synthesized from certain types of lactic 
acid bacteria mainly Leuconostoc mesenteroides, Streptococcus 
mutants. These pharmaceutical polymers have ability to get better 
water solubility, better biocompatibility, and appropriate 
biodegradability [28, 29].  
Chitosan 
Chitosan and its derivates are widely used for drug delivery by 
various pharmaceutical researchers [30]. These are also used in 
tissue engineering applications. These polymers have adequte 
biocompatibility, low toxicity, biodegradability, non-
immunogenicity, relatively low cost, water solubility, gelling ability, 
high viscosity and stabilizing properties [31]. Peluso et al., 2012, 
have successfully discovered the gels for local application in the 
buccal inflammation which is found to be a promising gel to reduce 
toxicity at the site of administration [32]. In the study, 
the investigators do the in vitro study and performed the 
characterization of chitosan based polymeric gels to test the action 
of formulation in buccal mucosal epithelial cells. The rheological 
properties of the prepared gels were tested by using cone-plate 
rheometer [33]. The in vitro showed better drug release and high 
permeability on pig cheek mucosa. The mucoadhesion ability was 
tested by using universal test machine [34]. All the results showed 
the prepared gels containing chitosan a better candidate to treat the 
oral disorders [35]. Factors affecting mucoadhesion of natural and 
synthetic polymers are depicted in [table 2]. 
  
Table 1: Examples of polymers used in buccal drug delivery (BDD) 
Criteria Category Examples References 
Source Semi-natural/natural 
Synthetic 
Agarose, chitosan, gelatine 
Hyaluronic acid 
Various gums (xanthan, guar, gellan, pectin and sodium alginate) 
Cellulose derivatives 
(CMC, thiolated CMC, sodium CMC, HEC, HPC, HPMC, MC) 
Poly(acrylic acid)-based polymers 
(CP, PC, PAA, copolymer of acrylic acid and PEG) 
Others 








CP, HEC, HPC, HPMC PAA, sodium CMC, sodium alginate 






Aminodextran, dimethylaminorthyl (DEAE)-dextran trimethylated chitosan 
Chitosan-EDTA, CP, CMC, pectin, PAA, PC, sodium alginate, sodium CMC, xanthan 
gum 
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Table 2: Various factors affecting the mucoadhesion of natural and synthetic polymers 
S. 
No. 
Factors affecting Details References 
1 Flexibility of 
polymeric chains 
It is one of the important factors which affect the polymeric mucoadhesion. The mucoadhesion 
strength depends upon the polymer flexibility. The appropriate flexibility of the polymer within the 
standard limits shows increase in degree of diffusion through the mucus layer which further results 
in better and strong mucoadhesion. It is seen than most of the water soluble (hydrophilic) polymers 
show lower flexibility and hence have less depth of penetration resulting in low strength of 
mucoadhesion. 
[46] 
2 The ability of the 
polymer to show 
hydrogen bonding  
If the polymer showed strongest bonding that is covalent bonding then because of very high 
bioadhesion, the formulation become toxic to the body. The polymers which have ability to show 
hydrogen bonding are accepted here because they show bioadhesion too with the acceptable 





The optimization of polymer concentration can help in producing the mucoadhesion with required 
strengths like high, medium or low. High the Polymer strength high will be the polymeric 
mucoadhesion. However, its low concentration will represent in low mucoadhesion strength. High 
polymeric strength represents high amount of polymeric networks for the interaction with the 
mucous which produces better mucoadhesion. 
[48] 
4 Molecular weight of 
the polymer 
It has been seen that different polymers show good adhesion property with mucin epithelial cells 
layer only at most favorable molecular weight amount of the polymer. Usually, it has been seen that 
the optimum molecular weight of the polymer ranges from 1 x 104 to 4 x 106 Daltons. Usually high 
molecular weight of the polymeric structure resulted in the increase in the entanglement between 
the mucin layer network and the polymeric structure. However, Low molecular weight of the 
polymeric structure resulted in the increase in the flexibility of the polymeric chain which further 
increases the penetration process which further resulted in increase in degree of diffusion through 
the mucus layer which further results in better and strong mucoadhesion. 
[49] 
5 Degree of hydration Wettability is important since the polymeric formulation need to be in contact with the mucin layer 
at the very first stage. Only after that penetration and mucoadhesion will take place. High wettability 
becomes important at the initial stage of contact of the polymeric surface with the mucous layer. 
However it is important to note that the degree of hydration should be in the required range. 
Because lesser wettability will result in lesser degree of contact and hence lesser mucoadhesion 
between the polymeric surface with the mucous layer. However high wettability will result in the 
slippery contact between polymeric surface with the mucous layer which resulted in the lesser 
mucosdhesion.  
[50] 
6 Cross-linking density Increase in the cross-linking density of the polymer would result in the decrease of the adhesion 
between the polymeric surface and the mucous layer. This is because of the decrease in the polymer 
network mobility. 
[51] 
7 Molecular charge on 
the polymer 
Cationic charge on the surface of the polymer enhances the interaction between its surface and 
mucin. This is because of the high electrostatic attractions as the mucin carries negative charge on 
its surface. On contrary, the use of anionic polymer reduces the chances of mucoadhesion because of 
reduced electrostatic attractions between polymeric surface and mucin layer. 
[52] 
8 Ionic Strength Ionic strength whether it is cationic or anionic strength can affect the internetwork between the 
structure of polymer and mucin layer of the epidermal cells. This is mainly because of the change in 
the polymeric structures. The conformation of polymeric structures changes with the change in the 
ionic strength (or shift in the environmental conditions from anionic to cationic or from cationic to 
anionic). 
[53] 
9 Moisture level at the 
site of administration 
The moisture level of the mucin layer also affect the degree of mucoadhesion. This moisture level 
varies with the type of body part where mucin layer is present. In the buccal cavity usually moisture 
level is high so will not cause any problem regarding mucoadhesion. However, during the buccal 
disorders like dryness of mouth and some other related disorders, this moisture level can change 
which may impact the degree of mucoadhesion. The degree of swelling of polymer also depends 
upon the moisture level present at the site of administration. 
[54] 
10 Applied pressure or 
force 
The depth of the mucoadhesion penetration is affected by the amount of total force or pressure 
which is applied on the delivery systems. By using the appropriate strength and suitable contact 
time, an adequate mucoadhesion can be achieved. 
[55] 
 
Buccal drug delivery system 
In 1847, it was first ever discovered that the drug absorption can 
also be possible when it is given through buccal cavity. The systemic 
absorption of the drug when it is given through buccal cavity is first 
ever tested on 1935. The results showed better results with better 
patient compliance as compared to other routes like nasal, ocular, 
vaginal extra routes. The buccal cavity is easily reachable 
(accessible) and heal itself rapidly after any damage of local stress. 
The buccal lining is also one of the robust lining of human body and 
can be used for systemic drug delivery [56]. As compared to other 
oral linings like sublingual route (floor of the mouth) [57], gingival 
route (gums) [58], linings around the lips, palatal mucosal route etc. 
[59], The buccal lining have different permeability to selective drugs, 
different anatomy, and desired length in order to keep the hold on 
the drug delivery dosage form like patches, tablets, semi-solid 
dosage form [60]. This buccal lining can be used not only for local 
drug delivery but can also be used for systemic drug delivery with 
better bioavailability. The local therapy by using buccal route mainly 
included the treatment of diseases like oral candidiasis, xerostomia, 
neuropathic pain, oral cancer, mucositis, dental caries, oral lesions, 
gingivitis, severe dryness of mouth due to lack production of saliva 
or lack in release of saliva etc [61-63]. The systemic therapy by using 
buccal route mainly includes the treatment of disorders in which 
prolonged and sustained release of drug is required. The buccal 
route is mainly used due its better trans-mucosal permeability 
which allows huge types of drugs to penetrate through it and 
reaches the systemic circulation [64]. However when compared with 
the sublingual route, buccal route becomes less permeable and does 
not allow the rapid action of the drug. In other words, the onset of 
action is slow when we select buccal route for drug delivery. 
However, this disadvantage of buccal route becomes advantageous if 
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we want to get prolonged and sustained release of the drug [65]. 
Hence, for the scientists, working on diseases where long release of 
drug is required with better bioavailability, then they prefer buccal 
route. This is because, the buccal route has a smooth, immobile and 
large surface which makes it better route for retentive drug delivery 
systems so that prolonged and sustained release of drug can be 
achieved [66]. 
Advantages and disadvantages of buccal drug delivery 
Advantages 
o The buccal lining is highly vascularised and better accessible for 
any dosage form to get better administered in the impacted area and 
can be easily removed from the impacted area. 
o Better patient compliance. 
o Buccal mucosa does not have the same harsh environmental 
factor like pH, enzymatic degradation, temperature sensitivity etc. as 
that of oral mucosa and hence can be used for harsh environment 
sensitive drugs. 
o As compared to other mucosal routes, in the buccal route there 
is very low enzyme activity. Hence, there is less enzymatic 
degradation of drug  
o Buccal delivery protects the active drug from acid hydrolysis 
which is possible in gastrointestinal tract and hence is helpful in 
avoiding the first pass metabolism of drug. 
Disadvantages 
o When compared with the sublingual route, buccal route 
becomes less permeable and does not allow the rapid action of the 
drug. 
o There is continuous salivary secretion in the mouth, near about 
0.5–2 liters per day. Such continuous salivary secretions lead to the 
dilution of the drug reducing the drug effectiveness. 
Various dosage form available for buccal delivery 
Till date various dosage forms like semisolid dosage forms 
(ointments, gels, pastes), tables, capsules etc. have been discovered 
which can be used in the buccal route for the drug release. Some of 
these dosage forms have been explained below:  
Semi-solid dosage forms (gels, pastes, ointments) 
Various semi-solid dosage forms like gels, ointments, pasts etc have 
been used in the oral buccal cavity. The sticky nature of these gels, 
ointments and pastes, resulted in better contact with the mucosal 
layer and the hydrophobic nature of the polymer used within these 
dosage forms do not allow the formulation to get diluted by salivary 
release [67]. 
Bioadhesive gels (Bioadhesive ointments) are frequently used for 
local wound therapy of the oral cavity. Bioadhesive pastes are also 
used for oral cavity. Now a day, most popularly used bioadhesive 
paste is marketed as Orabase. Orabase is a type of first generation 
bioadhesive paste and is widely used to treat mouth ulcers for a long 
time period. The paste acts as a barrier between the ulcers and 
saliva and do not allow the drug to get diluted and hence allow 
better and more penetration of drug to treat ulcers. The paste 
basically consists of finely ground pectin, fine gelatin and sodium 
CMC is dispersed in the combination of mineral oil and polyethylene 
gel base. This combination of mineral oil and polyethylene gel help 
to maintain the paste at its application site for about 15-150 min 
[68]. Usually the neutral poly-methacrylic acid and methyl ester 
were also used in the Orabase in order to avoid the irritation which 
is caused by the conventional ointments. The Bioadhesive ointments 
are usually more viscous then the bioadhesive gels and pastes and 
the high viscosity ointments usually contain carbopol (CP), which is 
mainly responsible for the high viscosity [69]. About 12.5% 
concentration of carbopol mainly responsible for sustained release 
of the drug from the ointment and showed increase in the 
absorption of the drug for about 5 h as compared to pastes/gels 
[70]. The release of Prednisolone drug in the high viscosity carbopol 
containing ointment in combination with the white petrolatum base 
has been tested by some researchers and the results showed better 
results as compared to that of pastes and gels containing same 
amount of active drug (Prednisolone) [71]. 
Other than pastes, gels, ointments, the use of hydrogels has also 
been discovered in order to treat buccal cavity related disorders. In 
1961, the first hydrogels are prepared by using poly (2-hydroxy 
ethyl methacrylate) by Wichterle and Lim. Hydrogels are basically 
hydrophilic polymer networks which are oriented in a three 
dimensional orientation. These hydrogels are capable to swell in 
water and also equally capable to spread in biological fluids like 
saliva. These hydrogels are able to absorb water just because of the 
presence of various types of hydrophilic group’s like-OH,-COOH,-
CONH2,-CONH,–SO3H etc [72]. The drug release from the hydrogels 
can be controlled and release mechanisms of the drug from the 
hydrogels can be modified by adjusting the factors like water 
content, polymer composition, crystallinity, and crosslinking density 
[73]. The delivery of lidocaine hydrochloride drug is tested by using 
the hydrogel prepared from the chitosan glutamate polymer. 
Chitosan glutamate polymer is basically a soluble salt form of the 
chitosan polymer. The buccal delivery of the drug lidocaine 
hydrochloride as an anaesthetic drug is found to show effective and 
better relief buccal cavity disorders like aphthosis and some other 
painful buccal cavity diseases [74]. 
Tablets 
Although semi-solid dosage forms are easy to administer and 
comfortable, however the active ingredient stability in the semi-
solid dosage forms is comparatively less as compared to the tablets. 
The tablets as well as patches offer better drug stability, long period 
of therapeutic drug concentration level at site of action and 
improved residence time [75]. These days some engineered tablets 
and patches have multi-layer systems and matrix devices. These 
engineered tablets contain adhesive layer and some other drug 
layers from which drug is released continually for long period of 
time [76, 77]. One more layer considered as drug impermeable layer 
is also included in these engineered and matrix tablets, to enhance 
the drug release unidirectional. This unidirectional release 
mechanism of the drug is important because this avoid the clearance 
of the drug through saliva released by the salivary glands. The most 
appropriate site of administration for the tablets, which avoids the 
chances of drug clearance from the buccal cavity, is by 
administrating the tablets or any other dosage form under the upper 
lip of the buccal cavity [78]. The marketed Buccastem®, is an 
adhesive tablet used for anti-emetic action. This buccastem contains 
the active ingredient as prochlorperazine maleate which is placed 
under the upper lip and shows better release of drug for prolonged 
period of time. Other than these benefits of using the oral buccal 
tablets, some other mechanisms like oscillatory action produced by 
talking and mastication action produced during chewing of any 
eatable item, can produce patient compliance making the use of 
tablets uncomfortable [79, 80].  
Till date a large number of muco-adhesive tablets have been 
investigated which are considered to have better muco-adhesive 
strength as they are used in combination with different polymers: 
Some of these muco-adhesive tablets have been mentioned below 
(table 3). 
Powder dosage forms 
Basically, a physical mixture of the drug with the bio-adhesive polymer 
can act as the powder dosage form which can be sprayed to the buccal 
mucosa in order to treat buccal disorders. Yamamoto et al., have 
successfully prepared a bio-adhesive buccal powder containing 
hydroxypropyl cellulose and active drug as beclomethasone 
diproprionate. The prepared bio-adhesive powder is then sprayed on 
the buccal cavity of the rats and the results were evaluated. The results 
showed that there is a significant increase in the residence time when 
we spray the powdered dosage form on the buccal cavity as compared 
to the related oral solution containing same drug and polymer in same 
concentration. The results showed that there was about 2.5% 
retention power of the active ingredient beclomethasone on the buccal 
mucosa after spraying for about 4 h [104]. 
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Table 3: Various combinations of API and polymers used in mucoadhesion of solid and semi-solid dosage form 
S. No. Active ingredient used Polymer used Reference 
1 Nifedipine Sodium alginate, Poly Vinyl Pyrollidone, and Poly Ethylene Glycol [81] 
2 Nimesulide Carbomer [82] 
3 Ondansetron Sodium carboxy methylcellulose, Hydroxy propylmethylcellulose [83] 
4 Metoclopramide Sodium carboxy methylcellulose, Hydroxy propylmethylcellulose [84] 
5 Benzydamine Gelatin, Sodium carboxy methylcellulose, Hydroxy propylmethylcellulose [85] 
6 Lignocaine HCl Sodium carboxy methylcellulose, Poly Vinylpyrollidone [86] 
7 Ergotamine tartrate  Carboxyvinyl polymer and Hydroxy Propyl Cellulose  [87] 
8 Cyanocobalamin Polyoxyethylene [88] 
9 Chlorpheniramine maleate Polyoxyethylene [89] 
10 Baclofen Sodium carboxymethyl celulose, sodium alginate, and Methocel [90] 
11 Ketoprofen Sodium alginate and shitosan [91] 
12 Lactoferrin Sodium alginate  [92] 
13 Omeprazole  Sodium alginate, Hydroxy propyl methyl cellulose [93] 
14 Salmon calcitonin Hakea gum obtained from Hakea gibbosa [94] 
15 Propranolol HCl Sodium carboxymetyl cellulose [95] 
16 Pravastatin sodium Carageenan [96] 
17 Piroxicam Hydroxy propyl methyl cellulose [97] 
18 Morphine sulfate Hydroxy propyl methyl cellulose [98] 
19 Metoprololtartarate Sodium carboxy methylcellulose, Hydroxy propylmethylcellulose [99] 
20 Testosterone Drum dried waxy maize  [100] 
21 Itraconazole Carbopol 934P, HPMC, Eudragit E 100 [101] 
22 Furosemide Soluphore, PEG 400, Polyvinyl alcohol, Cremophore, Eudragit, HPMC [102] 
23 Ranitidine HPMC, Carbopol 934P, Sodium Biocarbonate [103] 
 
Polymeric films 
Polymeric films are mainly used as coating formulation for various 
pharmaceutical tablet dosage forms, and the use these films was not 
attempted for buccal release. Later on 1990, the buccal film were 
considered to be more preferable over other adhesive dosage forms 
like tablets, capsules etc. as these polymeric buccal films have better 
flexibility and comfort related properties [105]. In addition to these 
properties, buccal polymeric films can show comparatively better 
residence time on the mucosa as compared to other dosage forms 
which can be easily diluted and easily washed away and can be 
removed from the buccal cavity by saliva. Other than these, these 
buccal polymeric films have the ability to protect the wound surface 
from various other bacterial infectious diseases and they are also 
helpful in reduction of pain [106]. 
Better flexibility, elasticity and softness are the ideal properties of 
polymeric buccal film. An ideal polymeric buccal film should also have be 
adequately strong so that it can withstand the stress conditions 
produced by mouth activity and should not get broken into pieces in 
mouth. In addition to these properties, an ideal polymeric buccal film 
must also have good bio-adhesive strength such that it should retain in 
the required area without breakage for the desired period of time [107]. 
Swelling of the polymeric films is a very common problem which cannot 
be neglected and cannot be completely removed. However, it can be 
reduced to some extent. An ideal polymeric buccal film if swell, then the 
swelling should be in the required range, such that it should not alter the 
physical and mechanical properties of the film [108]. The elasticity, 
softness, flexibility, bio-adhesive strength and other related properties 
should not get changed with the swelling of the film. Hence, we can say 
that the bio-adhesive, mechanical and swelling properties are the most 
critical properties in order to judge the efficiency of polymeric buccal 
film and hence these properties should be evaluated properly with 
standard tests and procedures [109]. These days polymeric buccal films 
have been prepared by using polymers like sodium CMC, PEG 400, CP 
934P, HPMC, PEG 400 etc. It has been seen that HPMC (hydroxypropyl 
methylcellulose) related polymeric buccal films were tougher and have 
more elasticity with more bio-adhesive property as compared to the 
polymeric buccal films prepared from sodium CMC films [110]. In vivo 
studies have also showed that the polymeric buccal films containing 
HPMC showed tolerable swelling as compared to the polymeric buccal 
films containing sodium CMC [111]. 
Polymeric patches 
On the other hand, polymeric buccal bio-adhesive patches are 
laminated thin films which can be single or multi layered depending 
on the need. These patches are available in various shapes. These 
patches can be round or can be oval in shape. These polymeric buccal 
patches have drug reservoir layer which is further connected with 
impermeable layer known as backing layer. This backing layer is very 
helpful in providing the unidirectional flow of the drug, contained in 
the polymeric layer, across buccal mucosa. These patches can be 1-3 
cm of range in their sizes. This small size of the polymeric buccal patch 
makes them more convenient and more comfortable for the user and 
hence increases the patient compliance. An ideal buccal polymeric 
patch should be flexible and ellipsoid in the shape so that it can fit 
easily onto the centre of buccal mucosa [112].  
The drug Acyclovir was delivered in the buccal cavity by using the 
polymeric buccal adhesive patches. The patch contained the polymer 
PEG, with copolymer acrylic acid, monomethyl ether monomethacrylate, 
an impermeable layer which is helpful in preventing the excessive 
dilution and washout through saliva. The in vivo studies showed that the 
patch once administered on the site remain there and releases the active 
drug Acyclovir for a period of about 22 h [113]. These evaluation tests 
showed it a good candidate for buccal delivery of the drug. 
Some literatures were studied in which the authors mentioned the 
formulation which contains API and some polymers (table 4). 
  
Table 4: Various combinations of API and polymers used in the formulation of mucoadhesive patches for buccal drug delivery 
S. No. Active ingredient used Polymer used Reference 
1 Isosorbide dinitrate HPMC phthalate [114] 
2 Lidocaine Hydroxy propyl Cellulose [115] 
3 Nifedipine Sodium alginate, Poly Ethylene Glycol [116] 
4 Protirelin Poly Vinyl Pyrrolidone [117] 
5 Tetracaine Hydroxy Propyl Cellulose [118] 
6 Ofloxacin Hydroxy Propyl Cellulose [119] 
7 Tetracycline  Atelocollagen [120] 
8 Triamcinolone acetonide Poloxamer, Hydroxy propyl methylcellulose  [121] 
9 Insulin Gelatin [122] 
10 Glibenclamide Chitosan [123] 
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Table 5: Commercial formulation intended for buccal delivery 
Product Manufacturer 
Testosterone Buccal Tablet (Straint) 
Desmopressin Buccal Tablet 
 
Columbia Laboratories Inc. 
Androdiol Buccal tablets (Cyclo-Diol SR) 
Norandrodiol Buccal Tablets (Cyclo-Nordiol SR) 
 
Ergo Pharm 
Insulin Buccal Spray 
ORALGEN (US) 
ORALIN (Canada) 
Generex Biotechnology Corporation 
Pilocarpine Buccal Tablet (PIOLOBUC) Cytokine Pharma Sciences Inc. 
Glyceryl Trinitrate (Suscard Buccal Tablet) Pharmax Limited 
Prochlorperazine Buccal Tablets (Buccastem) Britannia Pharmaceutical Ltd. 
Oral Transmucosal Fentanyl Citrate Solid Dosage Form (ACTIQ) Cephalon Inc. 
Vitamins Trans Buccal Spray Regency Medical research 
Lorazepam Buccal Tablets 
Oxazepam Buccal Tablets 
Wyeth Pharmaceuticals 
Nicotine Mucoadhesive Tablets 
Nicotine Chewing Gum 
Leo Pharmaceuticals 
Prochlorperazine Bioadhesive Buccal controlled release Tablet(Buccastem) 
Buprenorphine HCl Tablets (Subutex) 
Buprenorphine HCl, Naloxone HCl (Suboxane) 
 
Reckitt Benckiser 
Methyltestosterone Buccal Tablets (Metandren) Ciba-Geigy 
 
Table 6: Mucoadhesion polymers and their bioadhesion strength 






1 Carboxymethylcellulose Gelatin Polyethylene glycol 
2 Tragacanth Guar Gum Psyllium amberlite 
3 Sodium alginate Gum Karaya Thermally modified starch  
4 Carbopol 934 Chitosan Hydroxypropylcellulose 
5 Poly(acrylic acid/divinyl benzene) Acacia Polyvinyl pyrrolidone 
 
Table 7: Patented mucoadhesive formulations 
Patent number Inventor Original assignee Title 
US9320721B2 Ulrike Vollmer TESA LABTEC GmbH Mucoadhesive patch with opposite ratios of nonionic and 
anionic hydrocolloids in adhesive and backing layer 
US20020142042A1 Russell Mumper, Michael Jay University of Kentucky 
Research Foundation 
pH-sensitive mucoadhesive film-forming gels and 
wax-film composites suitable for topical and mucosal 
delivery of molecules 
EP2509586A1 Pierre Attali, Dominique 
Costantini, Caroline Lemarchand 
BioAlliance Pharma SA Mucoadhesive buccal tablets for the treatment of 
orofacial herpes 
EP1231900A1 David Francis Bain, Dale Munday, 
Calum Park, Omar Shakoor 
The Robert Gordon University, 
Univ Robert Gordon 
Bilayered buccal tablets comprising nicotine 
EP3173067A1 Ayca Yildiz Pekoz, Yildiz ozsoy 
Erginer, Derya Arslan 
Yildiz Pekoz Ayca Mucoadhesive buccal in situ gel formulation 
US8529939B2 David B. Masters, Eric P. Berg Gel-Del Technologies Inc Mucoadhesive drug delivery devices and methods of 
making and using thereof 
EP1107733A1 Douglas Joseph Dobrozsi Procter and Gamble Co Oral liquid mucoadhesive compositions 
WO2006105615A1 Ernest Alan Hewitt, 
Richard James Stenlake 
Ozpharma Pty Ltd Buccal delivery system 
 
US8475832B2 Garry L. Myers, Samuel D. 
Hilbert, Bill J. Boone, B. Arlie 
Bogue, Pradeep Sanghvi, 
Madhusudan Hariharan 
RB Pharmaceuticals Ltd Sublingual and buccal film compositions 
US20060198873A1 Shing Chan, Li-Lan Chen, 
Dushendra Chetty, John Liu 
SmithKline Beecham Corp  Orally dissolving films 
WO2008077130A2 Hassan Nached, Keith Freehauf, 
Peter Hanson  
Merial Limited Homogeneous paste and gel formulations 
US3257276A Robert H Broh-Kahn,  Ernest J 
Sasmor 
Laboratories for pharmaceutical 
Development Inc  
Oral analgesic preparation 




Buccal non polar spray or capsule 
US6110486A Harry A. Dugger, III Flemington Pharmaceutical Corp Buccal polar spray or capsule 
US20090263476A1 Christopher N. Jobdevairakkam,  
Vikram Katragadda 
Navinta LLC Composition of Rapid Disintegrating Direct 
Compression Buccal Tablet 
US20060002989A1 Salah Ahmed Lianli Li 
Venkatesh Naini 
Teva Women s Health Inc Formulations of sumatriptan for absorption across 
biological membranes, and methods of making and 
using the same 
CA1299105C John A. Mccarty Key Pharmaceuticals Inc Buccal formulation 
Singh et al. 
Int J App Pharm, Vol 11, Issue 6, 2019, 18-29 
26 
Factors affecting polymeric bioadhesion 
1. Hydrophilicity of the drug. 
2. Formulation type (Tablets, gels, semi-solid dosage forms, 
patches, films etc). 
3. Molecular weight of the polymer used. 
4. Hydrogen bonding and glass transition temperature of polymer 
used. 
5. pH of saliva. 
6. Buccal cavity movement by talking, drinking and eating etc. 
7. Acid dissociation constant of the drug. 
8. Concentration of the polymer used. 
9. Swelling index of the polymer. 
10. Contact time of prepared formulation on the applied surface. 
Gels 
Gels are the classical formulations which are used for topical 
administration of various drugs. These gels offer various beneficial 
properties as compared to other dosage forms for example: gels are 
easy to get applied on the surface, they show better spreadibility and 
better bio-compatibility. These gels also show better physico-
chemical properties which make these gels more appropriate dosage 
formulations as compared to others. For example, Hydrogels [124]. 
These hydrogels are modified form of gels with better hydrophilicity 
which make them easy to penetrate and better spreadibility. 
Hydrogels are three dimensional polymers with better cross linking 
which are basically synthesized from same or different monomers 
with hydrophilic nature [125]. These polymers have the ability to 
shrink or swell depending upon the environmental conditions where 
they have applied. Hydrogels have ability to get modified as per the 
needs of the drug’s physical and chemical properties which itself 
increases the stability and release of the drug incorporated. The gels 
have three dimensional cross linking structures and hence there are 
a number of gaps in between these linking where the drug can be 
easily placed. All these properties make the gels a better candidate 
for tissue engineering, regenerative medicine, diagnostic biomedical 
sensors, and controlled drug delivery [126]. List of patented 
mucoadhesive formulation is depicted in (table 7). 
CONCLUSION 
This outline is about the mucoadhesive dosage forms which may be 
constructive tool for the capable of designing novel mucoadhesive 
drug delivery system as it offers prolonged contact at the site of 
administration. The formulation of mucoadhesive drug delivery 
system depends on the selection of appropriate polymer with 
immense mucosal adhesive properties and biocompatibility. There 
is no uncertainty that the oral route is the most favorable route of 
drug delivery. Mucoadhesive drug delivery has diverse applications 
including development of novel mucoadhesive, design of the novel 
devices, mechanisms and permeation enhancement.  
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